Synthetic cannabinoids tripled seizure risk in ER drug cases, while cannabis was protective
Among nearly 24,000 emergency department presentations for recreational drug toxicity across Europe, synthetic cannabinoids nearly tripled the odds of seizures while natural cannabis was associated with lower seizure risk.
Quick Facts
What This Study Found
Of 23,947 ED presentations, 4.2% involved seizures. Synthetic cannabinoids were associated with 2.90 times higher seizure odds (95% CI 2.19-3.84), and fentanyl with 2.63 times (95% CI 1.20-5.80). Natural cannabis was associated with lower seizure incidence (OR 0.65, 95% CI 0.50-0.86). Patients with seizures had significantly higher rates of coma, cardiac arrest, intubation, ICU admission, and death.
Key Numbers
23,947 presentations (2014-2017). 1,013 (4.2%) with seizures. Synthetic cannabinoids: OR 2.90 (95% CI 2.19-3.84). Fentanyl: OR 2.63 (95% CI 1.20-5.80). Cannabis: OR 0.65 (95% CI 0.50-0.86). Heroin: OR 0.46.
How They Did This
Retrospective analysis of the European Drug Emergencies Plus (Euro-DEN Plus) Network database covering ED presentations with acute recreational drug toxicity from January 2014 to December 2017 across multiple European centers.
Why This Research Matters
Synthetic cannabinoids are often perceived as cannabis alternatives, but this large dataset shows they carry fundamentally different and more dangerous clinical profiles, particularly regarding seizure risk.
The Bigger Picture
The protective association of natural cannabis with seizures, contrasted with the elevated risk from synthetic cannabinoids, underscores that these products should not be considered interchangeable.
What This Study Doesn't Tell Us
Observational data. Seizure occurrence may be underreported. Self-reported drug use may be inaccurate. Polysubstance use common. Cannot establish causation.
Questions This Raises
- ?Which specific synthetic cannabinoids carry the highest seizure risk?
- ?Is the cannabis protective association a direct pharmacological effect or a confounder?
Trust & Context
- Key Stat:
- 2.9x seizure risk for synthetic cannabinoids vs 0.65x for cannabis
- Evidence Grade:
- Large multi-center dataset with clear associations, but observational design and self-reported drug use.
- Study Age:
- 2019 study using 2014-2017 data.
- Original Title:
- Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set.
- Published In:
- Neurotoxicology, 73, 183-187 (2019)
- Authors:
- Wolfe, Caitlin E, Wood, David M(5), Dines, Alison, Whatley, Benjamin P, Yates, Christopher, Heyerdahl, Fridtjof, Hovda, Knut Erik, Giraudon, Isabelle, Dargan, Paul I
- Database ID:
- RTHC-02352
Evidence Hierarchy
Looks back at existing records to find patterns.
What do these levels mean? →Frequently Asked Questions
Are synthetic cannabinoids more dangerous than natural cannabis?
In this large ER dataset, synthetic cannabinoids nearly tripled seizure risk while natural cannabis was associated with reduced seizure odds, demonstrating fundamentally different safety profiles.
What happens when people have seizures from drug use?
Patients who seized had significantly higher rates of coma, cardiac arrest, intubation, ICU admission, and death compared to those without seizures.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBT-cannabis-recovery
- THC-purity-potency-label-meaning
- cannabis-relapse-cycle-pattern
- cold-turkey-vs-taper-quit-weed
- dab-concentrate-addiction-withdrawal
- dating-sober-after-quitting-weed
- delta-8-addiction-withdrawal
- edible-addiction-withdrawal-different
- edibles-psychosis-emergency-room
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- healthiest-way-to-consume-cannabis
- help-someone-quit-weed
- how-cannabis-products-made-concentrates-edibles
- how-to-quit-weed
- journaling-weed-withdrawal
- laced-weed-fentanyl-contaminated-vape
- legal-weed-vs-street-weed-quality-safety
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-dabs-withdrawal
- quitting-edibles-withdrawal
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- sativa-vs-indica-difference-myth
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-potency-withdrawal
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-02352APA
Wolfe, Caitlin E; Wood, David M; Dines, Alison; Whatley, Benjamin P; Yates, Christopher; Heyerdahl, Fridtjof; Hovda, Knut Erik; Giraudon, Isabelle; Dargan, Paul I. (2019). Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set.. Neurotoxicology, 73, 183-187. https://doi.org/10.1016/j.neuro.2019.04.003
MLA
Wolfe, Caitlin E, et al. "Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set.." Neurotoxicology, 2019. https://doi.org/10.1016/j.neuro.2019.04.003
RethinkTHC
RethinkTHC Research Database. "Seizures as a complication of recreational drug use: Analysi..." RTHC-02352. Retrieved from https://rethinkthc.com/research/wolfe-2019-seizures-as-a-complication
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.